Scholtes Bret's Form 4 filing
Guardion Health Sciences, Inc. (GHSI) · filed Sep 1, 2021
- Accession no.
- 0001493152-21-021791
- Filed
- Sep 1, 2021
- Trade date
- Aug 30-31, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $12.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scholtes BretCIK 0001490606 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This sales price reflects a weighted average of multiple prices ranging from $1.245 to $1.27. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F2
This sales price reflects a weighted average of multiple prices ranging from $1.21 to $1.25. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
Referenced by the price of 1 transaction in Table I.